• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page  


Search

Follow us...

Latest

  • Synergistic Actions of Alpelisib and Melatonin in Breast Cancer Cell Lines with PIK3A Gene Mutation
  • In Vitro Transfection of Up-Regulated Genes Identified in Favorable-Outcome Neuroblastoma into Cell Lines
  • Melatonin Can Modulate Neurodegenerative Diseases by Regulating Endoplasmic Reticulum Stress
  • Neuropeptide Y- and somatostatin-like immunoreactivities in ganglioneuroma, ganglioneuroblastoma and neuroblastoma
  • Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis
  • Do Anti-Oxidants Vitamin D3, Melatonin, and Alpha-Lipoic Acid Have Synergistic Effects with Temozolomide on Cultured Glioblastoma Cells?
  • Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO
  • Expression of somatostatin and its receptor 1-5 in endometriotic tissues and cells
  • Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers
  • The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: what do we know so far?
  • Effects of prolactin on intracellular calcium concentration and cell proliferation in human glioma cells
  • Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma
  • Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
  • Tumor Microenvironment and Metabolism: Role of the Mitochondrial Melatonergic Pathway in Determining Intercellular Interactions in a New Dynamic Homeostasis
  • Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression
  • Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue
  • Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats
  • Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats

Most Read

  • The Di Bella Method (DBM)
  • All-trans-retinoic acid and cancer
  • About melatonin - 1996
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Bibliography
  • Somatostatin in oncology, the overlooked evidences
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • How effective is chemo therapy?
  • Vademecum
  • Frequently Asked Questions
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients